摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

diosgenyl 2,3,4-tri-O-acetyl-α-L-rhamnopyranosyl-(1->4)-3,6-di-O-benzoyl-2-deoxy-2-[5-(1,2-dithiolan-3-yl)pentanamido]-β-D-glucopyranoside | 1202534-78-8

中文名称
——
中文别名
——
英文名称
diosgenyl 2,3,4-tri-O-acetyl-α-L-rhamnopyranosyl-(1->4)-3,6-di-O-benzoyl-2-deoxy-2-[5-(1,2-dithiolan-3-yl)pentanamido]-β-D-glucopyranoside
英文别名
——
diosgenyl 2,3,4-tri-O-acetyl-α-L-rhamnopyranosyl-(1->4)-3,6-di-O-benzoyl-2-deoxy-2-[5-(1,2-dithiolan-3-yl)pentanamido]-β-D-glucopyranoside化学式
CAS
1202534-78-8
化学式
C67H89NO17S2
mdl
——
分子量
1244.57
InChiKey
APYPSXZQYDZGTO-IIUPIHTFSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    10.67
  • 重原子数:
    87.0
  • 可旋转键数:
    18.0
  • 环数:
    11.0
  • sp3杂化的碳原子比例:
    0.7
  • 拓扑面积:
    215.98
  • 氢给体数:
    1.0
  • 氢受体数:
    19.0

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    diosgenyl 2,3,4-tri-O-acetyl-α-L-rhamnopyranosyl-(1->4)-3,6-di-O-benzoyl-2-deoxy-2-[5-(1,2-dithiolan-3-yl)pentanamido]-β-D-glucopyranosidesodium methylate 作用下, 以 甲醇二氯甲烷 为溶剂, 以96%的产率得到diosgenyl α-L-rhamnopyranosyl-(1->4)-2-deoxy-2-[5-(1,2-dithiolan-3-yl)pentanamido]-β-D-glucopyranoside
    参考文献:
    名称:
    Structural analogues of diosgenyl saponins: Synthesis and anticancer activity
    摘要:
    Saponins display various biological activities including anti-tumor activity. Recently intensive research has been focused on developing saponins for tumor therapies. The diosgenyl saponin dioscin is one of the most common steroidal saponins and exhibits potent anticancer activity in several human cancer cells through apoptosis-inducing pathways. In this paper, we describe the synthesis of several diosgenyl saponin analogues containing either a 2-amino-2-deoxy-beta-D-glucopyranosyl residue or an alpha-L-rhamnopyranosyl-(1 -> 4)-2-amino-2-deoxy-beta-D-glucopyranosyl residue with different acyl substituents on the amino group. The cytotoxic activity of these compounds was evaluated in MCF-7 breast cancer cells and HeLa cervical cancer cells. Structure-activity relationship studies show that the disaccharide saponin analogues are in general less active than their corresponding monosaccharide analogues. The incorporation of an aromatic nitro functionality into these saponin analogues does not exhibit significant effect on their cytotoxic activity. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2009.09.046
  • 作为产物:
    描述:
    、 Thioctic acid 在 O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate 、 N,N-二异丙基乙胺 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 16.0h, 以83%的产率得到diosgenyl 2,3,4-tri-O-acetyl-α-L-rhamnopyranosyl-(1->4)-3,6-di-O-benzoyl-2-deoxy-2-[5-(1,2-dithiolan-3-yl)pentanamido]-β-D-glucopyranoside
    参考文献:
    名称:
    Structural analogues of diosgenyl saponins: Synthesis and anticancer activity
    摘要:
    Saponins display various biological activities including anti-tumor activity. Recently intensive research has been focused on developing saponins for tumor therapies. The diosgenyl saponin dioscin is one of the most common steroidal saponins and exhibits potent anticancer activity in several human cancer cells through apoptosis-inducing pathways. In this paper, we describe the synthesis of several diosgenyl saponin analogues containing either a 2-amino-2-deoxy-beta-D-glucopyranosyl residue or an alpha-L-rhamnopyranosyl-(1 -> 4)-2-amino-2-deoxy-beta-D-glucopyranosyl residue with different acyl substituents on the amino group. The cytotoxic activity of these compounds was evaluated in MCF-7 breast cancer cells and HeLa cervical cancer cells. Structure-activity relationship studies show that the disaccharide saponin analogues are in general less active than their corresponding monosaccharide analogues. The incorporation of an aromatic nitro functionality into these saponin analogues does not exhibit significant effect on their cytotoxic activity. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2009.09.046
点击查看最新优质反应信息

同类化合物

(5β)-17,20:20,21-双[亚甲基双(氧基)]孕烷-3-酮 (5α)-2′H-雄甾-2-烯并[3,2-c]吡唑-17-酮 (3β,20S)-4,4,20-三甲基-21-[[[三(异丙基)甲硅烷基]氧基]-孕烷-5-烯-3-醇-d6 (25S)-δ7-大发酸 (20R)-孕烯-4-烯-3,17,20-三醇 (11β,17β)-11-[4-({5-[(4,4,5,5,5-五氟戊基)磺酰基]戊基}氧基)苯基]雌二醇-1,3,5(10)-三烯-3,17-二醇 齐墩果酸衍生物1 黄麻属甙 黄芪皂苷III 黄芪皂苷 II 黄芪甲苷 IV 黄芪甲苷 黄肉楠碱 黄果茄甾醇 黄杨醇碱E 黄姜A 黄夹苷B 黄夹苷 黄夹次甙乙 黄夹次甙乙 黄夹次甙丙 黄体酮环20-(乙烯缩醛) 黄体酮杂质EPL 黄体酮杂质1 黄体酮杂质 黄体酮杂质 黄体酮EP杂质M 黄体酮EP杂质G(RRT≈2.53) 黄体酮EP杂质F 黄体酮6-半琥珀酸酯 黄体酮 17alpha-氢过氧化物 黄体酮 11-半琥珀酸酯 黄体酮 麦角甾醇葡萄糖苷 麦角甾醇氢琥珀酸盐 麦角甾烷-6-酮,2,3-环氧-22,23-二羟基-,(2b,3b,5a,22R,23R,24S)-(9CI) 麦角甾烷-3,6,8,15,16-五唑,28-[[2-O-(2,4-二-O-甲基-b-D-吡喃木糖基)-a-L-呋喃阿拉伯糖基]氧代]-,(3b,5a,6a,15b,16b,24x)-(9CI) 麦角甾烷-26-酸,5,6:24,25-二环氧-14,17,22-三羟基-1-羰基-,d-内酯,(5b,6b,14b,17a,22R,24S,25S)-(9CI) 麦角甾-8-烯-3-醇 麦角甾-8,24(28)-二烯-26-酸,7-羟基-4-甲基-3,11-二羰基-,(4a,5a,7b,25S)- 麦角甾-7,22-二烯-3-酮 麦角甾-7,22-二烯-17-醇-3-酮 麦角甾-5,24-二烯-26-酸,3-(b-D-吡喃葡萄糖氧基)-1,22,27-三羟基-,d-内酯,(1a,3b,22R)- 麦角甾-5,22,25-三烯-3-醇 麦角甾-4,6,8(14),22-四烯-3-酮 麦角甾-1,4-二烯-3-酮,7,24-二(乙酰氧基)-17,22-环氧-16,25-二羟基-,(7a,16b,22R)-(9CI) 麦角固醇 麦冬皂苷D 麦冬皂苷D 麦冬皂苷 B